跳至主要内容
临床试验/NCT06452212
NCT06452212已完成不适用

A Non-Interventional, Modified Delphi Study to Establish Consensus Recommendations on the Optimal Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Patients in South Korea

Astellas Pharma Korea, Inc.1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2024年7月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
23
试验地点
1
主要终点
Treatment plans for patients with mHSPC

研究概览

简要总结

The purpose of this study is to establish an expert consensus recommendations on managing patients with mHSPC in South Korea, and to provide clinicians with a comprehensive guide to support their clinical decision making. There are no secondary objectives for this study.

详细描述

Data collection for this study will be conducted through 2 rounds of web-based surveys of health care professionals (HCPs). A meeting with the panelists will be held as a 3rd round if a consensus for pre determined key questions is not achieved after the 2 rounds of the survey.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Urologist from university hospitals in South Korea.
  • Has a minimum 10 years of practice experience (experience as a military or public health doctor could be considered practice experience)
  • Sees a minimum of 50 mHSPC patients in a year.
  • At least 10 publications in SCIE (Science Citation Index Expanded) journals in the past 5 years.

排除标准

  • Urologist in private practice.

结局指标

主要结局

Treatment plans for patients with mHSPC

时间窗: Up to 7 days

Treatment plans for patients with mHSPC within the local healthcare environment will be collected via online surveys and a consensus meeting will be held if required.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验